Methyl-CpG2-binding protein 2 mediates overlapping mechanisms across brain disorders
Citation:
Bach S, Ryan NM, Guasoni P, Corvin AP, El-Nemr RA, Khan D, Sanfeliu A, Tropea D. Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders. Scientific Reports. 2020 Dec 17;10(1):22255Download Item:
Abstract:
MECP2 and its product, Methyl-CpG binding protein 2 (MeCP2), are mostly known for their association to Rett Syndrome (RTT), a rare neurodevelopmental disorder. Additional evidence suggests that MECP2 may underlie other neuropsychiatric and neurological conditions, and perhaps modulate common presentations and pathophysiology across disorders. To clarify the mechanisms of these interactions, we develop a method that uses the binding properties of MeCP2 to identify its targets, and in particular, the genes recognized by MeCP2 and associated to several neurological and neuropsychiatric disorders. Analysing mechanisms and pathways modulated by these genes, we find that they are involved in three main processes: neuronal transmission, immuno-reactivity, and development. Also, while the nervous system is the most relevant in the pathophysiology of the disorders, additional systems may contribute to MeCP2 action through its target genes. We tested our results with transcriptome analysis on Mecp2-null models and cells derived from a patient with RTT, confirming that the genes identified by our procedure are directly modulated by MeCP2. Thus, MeCP2 may modulate similar mechanisms in different pathologies, suggesting that treatments for one condition may be effective for related disorders.
Author's Homepage:
http://people.tcd.ie/tropeadDescription:
PUBLISHED
Author: Tropea, Daniela
Type of material:
Journal ArticleCollections
Series/Report no:
Scientific Reports;10;
1;
Availability:
Full text availableSubject (TCD):
NeuroscienceDOI:
10.1038/s41598-020-79268-0Metadata
Show full item recordLicences: